(EMAILWIRE.COM, February 09, 2019 ) #Download Free PDF Brochure of Structural Heart Devices Market at
The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2% during the forecast period. High growth of this segment can be attributed to growing number of transcatheter aortic valve replacement procedures performed across globe, efficacy and durability of these products, & growing number of regulatory approvals for heart valve devices.
#Table of Content
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Structural Heart Devices Market, By Product
7 Structural Heart Devices Market, By Procedure
8 Structural Heart Devices Market, By Region
9 Competitive Landscape
10 Company Profiles
Inquire for More Details on Structural Heart Devices Market at
Report describes and studies global structural heart devices market, by product, procedure, and region. It provides detailed information regarding major factors influencing growth of this market and the regulatory analysis impacting market dynamics. The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices.
Key Target Audience:
Cardiac surgery centers
Structural heart device distributors
Medical service providers
Manufacturers of structural heart devices
Structural heart surgeons
The major players operating in the structural heart devicesmarket areEdwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK).
Place the Order Now on Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) – Global Forecast to 2023 report at http://www.reportsnreports.com/purchase.aspx?name=1646271 .
The report describes and studies the global structural heart devices market, by product, procedure, and region. It provides detailed information regarding the major factors influencing the growth of this market and the regulatory analysis impacting market dynamics. The heart valve devices segment is expected to register the highest CAGR during the forecast period.
Objectives of the Study:
To define, describe, and forecast the global structural heart devices market, by product, procedure, and region
To provide detailed information regarding factors influencing market growth (drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders
To forecast the size of the structural heart devices market in North America, Europe, Asia Pacific, and the Rest of the World
To profile the key players in the global structural heart devices market and comprehensively analyze their core competencies
To track and analyze competitive developments, such as product launches & approvals, acquisitions, expansions, and partnerships & agreements, of the leading players in the structural heart devices market